752
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Interlaboratory Study of the Primary Antibody Response to Sheep Red Blood Cells in Outbred Rodents Following Exposure to Cyclophosphamide or Dexamethasone

, , , , , , , & show all
Pages 233-238 | Received 19 Jan 2007, Accepted 13 Mar 2007, Published online: 09 Oct 2008

Figures & data

FIG. 1 Cyclophosphamide Inhibition of the Antibody Response to sRBC from a Representative Laboratory. Dose response curves for percent inhibition were plotted in Microsoft Excel, a best-fitting trendline drawn, and the dose of each compound to inhibit the response (AFC: Antibody Forming Cell/106 splenocytes; AFC spleen: AFC/spleen; ELISA) by 50% (ID50) in rats (R) or mice (M) was visually determined.

FIG. 1 Cyclophosphamide Inhibition of the Antibody Response to sRBC from a Representative Laboratory. Dose response curves for percent inhibition were plotted in Microsoft Excel, a best-fitting trendline drawn, and the dose of each compound to inhibit the response (AFC: Antibody Forming Cell/106 splenocytes; AFC spleen: AFC/spleen; ELISA) by 50% (ID50) in rats (R) or mice (M) was visually determined.

TABLE 1 Lowest dose of cyclophosphamide at which statistical significance was observed and percent inhibition

TABLE 2 Cyclophosphamide ID50 values from all four laboratories using the AFC and ELISA assays to evaluate immunosuppression

TABLE 3 Lowest dose of dexamethasone at which statistical significance was observed and percent inhibition

TABLE 4 Dexamethasone ID50 values from all four laboratories using the AFC and ELISA assays to evaluate immunosuppression

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.